4.6 Article

Cancer cells with high-metastatic potential promote a glycolytic shift in activated fibroblasts

Journal

PLOS ONE
Volume 15, Issue 6, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0234613

Keywords

-

Funding

  1. JSPS KAKENHI [15K21646, 17H04991, 17K19625]
  2. Japan Agency for Medical Research and Developmentfrom, AMED [16ae0101011h0003]
  3. JSPS [15J10473]
  4. [16cm0106402h0001]
  5. Grants-in-Aid for Scientific Research [17K19625, 17H04991, 15J10473, 15K21646] Funding Source: KAKEN

Ask authors/readers for more resources

Cancer-associated fibroblasts (CAFs) are activated fibroblasts and are the major stromal component in various types of malignancies. CAFs often undergo metabolic reprogramming to create an appropriate microenvironment for cancer progression. However, it remains unclear whether the metastatic properties of cancer cells affect aerobic glycolysis in stromal cells. Here, we show that gastric cancer (GC) cells with high metastatic potential strongly promote the metabolic switch from oxidative phosphorylation to aerobic glycolysis in fibroblasts. Transcriptome analysis showed that the expression of glycolysis-related genes, such as LDHA and ENO2, significantly changed in fibroblasts when they were cocultured with cancer cells with high metastatic potential compared to fibroblasts incubated with cancer cells with low metastatic potential. Glucose uptake, lactate production and oxygen consumption in fibroblasts were changed by coculture with GC cells with high metastatic potential. Thus, metabolic reprogramming in CAFs may reflect the metastatic properties of GC cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

How cancer cells dictate their microenvironment: present roles of extracellular vesicles

Yutaka Naito, Yusuke Yoshioka, Yusuke Yamamoto, Takahiro Ochiya

CELLULAR AND MOLECULAR LIFE SCIENCES (2017)

Article Gastroenterology & Hepatology

MicroRNA-125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection

Tomonari Shimagaki, Tomoharu Yoshizumi, Norifumi Harimoto, Sachiyo Yoshio, Yutaka Naito, Yusuke Yamamoto, Takahiro Ochiya, Yoshihiro Yoshida, Tatsuya Kanto, Yoshihiko Maehara

HEPATOLOGY RESEARCH (2018)

Article Gastroenterology & Hepatology

The antiviral effects of human microRNA miR-302c-3p against hepatitis B virus infection

Susumu Hamada-Tsutsumi, Yutaka Naito, Seiichi Sato, Akinori Takaoka, Keigo Kawashima, Masanori Isogawa, Takahiro Ochiya, Yasuhito Tanaka

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Article Biochemistry & Molecular Biology

Cancer extracellular vesicles contribute to stromal heterogeneity by inducing chemokines in cancer-associated fibroblasts

Yutaka Naito, Yusuke Yamamoto, Naoya Sakamoto, Iwao Shimomura, Akiko Kogure, Minami Kumazaki, Akira Yokoi, Masakazu Yashiro, Tohru Kiyono, Kazuyoshi Yanagihara, Ryou-u Takahashi, Kosei Hirakawa, Wataru Yasui, Takahiro Ochiya

ONCOGENE (2019)

Article Cell Biology

Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination

Marco Montagner, Rahul Bhome, Steven Hooper, Probir Chakravarty, Xiao Qin, Jahangir Sufi, Ajay Bhargava, Colin D. H. Ratcliffe, Yutaka Naito, Arianna Pocaterra, Christopher J. Tape, Erik Sahai

NATURE CELL BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Extracellular Vesicles in Cancer Metastasis: Potential as Therapeutic Targets and Materials

Akiko Kogure, Yusuke Yoshioka, Takahiro Ochiya

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Gastroenterology & Hepatology

Identification of microRNA-96-5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma

Takeshi Matsui, Susumu Hamada-Tsutsumi, Yutaka Naito, Masanori Nojima, Etsuko Iio, Akihiro Tamori, Shoji Kubo, Tatsuya Ide, Yasuteru Kondo, Yuichiro Eguchi, Atsumasa Komori, Yuji Morine, Mitsuo Shimada, Tohru Utsunomiya, Ken Shirabe, Koichi Kimura, Yoichi Hiasa, Natthaya Chuaypen, Pisit Tangkijvanich, Aya Naiki-Ito, Satoru Takahashi, Takahiro Ochiya, Yasuhito Tanaka

Summary: The miRNA clusters miR-183/96/182 and miR-217/216a/216b are significantly upregulated in nonviral hepatocellular carcinoma (NBNC-HCC). High levels of miR-182-5p and miR-217-5p, but low levels of miR-96-5p, in tumor tissues are associated with poor recurrence-free survival of NBNC-HCC patients. Further upregulation of miR-96-5p in tumors may have an inhibitory effect on recurrence, suggesting its potential as a tumor suppressor in NBNC-HCC patients at high risk of recurrence. Transfection of miR-96-5p mimic induced apoptosis of HepG2 cells and suppressed proliferation and invasion, indicating its potential antitumor effects.

HEPATOLOGY RESEARCH (2022)

Review Oncology

Intercellular crosstalk between cancer cells and cancer-associated fibroblasts via extracellular vesicles

Yutaka Naito, Yusuke Yoshioka, Takahiro Ochiya

Summary: Intercellular communication plays a crucial role in cancer initiation and progression, with cancer-associated fibroblasts (CAFs) being a key component in this process. Recent research on extracellular vesicles (EVs) as regulators of intercellular communication has shown significant advancements. EVs facilitate the transfer of functional molecules to recipient cells, influencing the communication between cancer cells and CAFs and promoting cancer progression.

CANCER CELL INTERNATIONAL (2022)

Article Oncology

RIOK2 Contributes to Cell Growth and Protein Synthesis in Human Oral Squamous Cell Carcinoma

Yusuke Matsuzaki, Yutaka Naito, Nami Miura, Taisuke Mori, Yukio Watabe, Seiichi Yoshimoto, Takahiko Shibahara, Masayuki Takano, Kazufumi Honda

Summary: The expression of RIOK2 is associated with poorer overall survival in patients with tongue squamous cell carcinoma (TSCC), and it is an independent prognostic factor. Inhibition of RIOK2 expression can decrease cell growth and S6 ribosomal protein expression in oral squamous cell carcinoma cell lines, as well as significantly reduce protein synthesis in cancer cells. RIOK2 has potential as a novel therapeutic target for TSCC treatment.

CURRENT ONCOLOGY (2023)

Review Biochemistry & Molecular Biology

Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications

Nobuyoshi Kosaka, Akiko Kogure, Tomofumi Yamamoto, Fumihiko Urabe, Wataru Usuba, Marta Prieto-Vila, Takahiro Ochiya

EXPERIMENTAL AND MOLECULAR MEDICINE (2019)

Review Cell Biology

Cross-talk between cancer cells and their neighbors via miRNA in extracellular vesicles: an emerging player in cancer metastasis

Akiko Kogure, Nobuyoshi Kosaka, Takahiro Ochiya

JOURNAL OF BIOMEDICAL SCIENCE (2019)

Meeting Abstract Oncology

The mechanistic insight of bone marrow-metastasized breast cancer cell survival in nutrient-limited conditions

Akiko Kogure, Nobuyoshi Kosaka, Takahiro Ochiya

CANCER SCIENCE (2018)

No Data Available